Homatropine

Homatropine

SCHEMBL23468168

CN1[C@@H]2CC[C@@H]1CC(OC(=O)C(O)c1ccccc1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 1.00
CYP2D6 P10635 3/20 1.00
CYP2C9 P11712 1/20 1.00
HSD17B10 Q99714 1/20 1.00
CHRM2 P08172 6/20 0.97
CHRM1 P11229 6/20 0.97
CHRM3 P20309 6/20 0.97
CHRM5 P08912 5/20 0.97
CHRM4 P08173 4/20 0.97
BLM P54132 2/20 0.97
SMN1; SMN2 Q16637 1/20 0.97
TDP1 Q9NUW8 1/20 0.97
HTR2C P28335 3/20 0.70
ADRA2C P18825 2/20 0.70
ADRA1A P35348 2/20 0.70
HRH1 P35367 2/20 0.70
ADRA1D P25100 2/20 0.70
KDM4E B2RXH2 1/20 0.70
MEN1 O00255 1/20 0.70
POLB P06746 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Homatropine SCHEMBL15275620 1.00 LMNA (1.00) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL23969 1.00 LMNA (1.00) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL9653008 1.00 LMNA (1.00) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL23970 1.00 LMNA (1.00) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL41951 0.99 CHRM2 (1.00) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL41950 0.99 CHRM2 (1.00) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL220965 0.99 LMNA (0.97) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL220964 0.99 LMNA (0.97) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL14672464 0.97 LMNA (0.95) LMNACYP2D6CYP2C9HSD17B10CHRM2
Homatropine SCHEMBL10743457 0.97 LMNA (0.95) LMNACYP2D6CYP2C9HSD17B10CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11026942-B2 Agent for preventing and/or treating Alzheimer's disease KYOTO UNIVERSITY (JP) 2021-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11026942-B2 Agent for preventing and/or treating Alzheimer's disease PSEN1, NOS1, ACHE LMNA 1393/4885CYP2D6 1064/4885CYP2C9 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.